Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|March 25, 2006
Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancerNiels Reinmuth, Michael Meister, Thomas Muley, et al.
Virchows Archiv : an International Journal of Pathology|December 6, 2015
Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 casesArne Warth, Sandrina Körner, Roland Penzel, et al.
International Journal of Oncology|December 12, 2018
Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancerRebecca Weber, Michael Meister, Thomas Muley, et al.
Histopathology|August 14, 2012
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsiesArne Warth, Thomas Muley, Esther Herpel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survivalArne Warth, Thomas Muley, Michael Meister, et al.
Cancers|April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for RedefinitionPhilip Baum, Samantha Taber, Stella Erdmann, et al.
Frontiers in Oncology|June 5, 2023
Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Frontiers in Oncology|December 9, 2022
Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
Frontiers in Oncology|February 17, 2022
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative StudyMarc A Schneider, Adriana Rozy, Sabine Wrenger, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|March 25, 2006
Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancerNiels Reinmuth, Michael Meister, Thomas Muley, et al.
Virchows Archiv : an International Journal of Pathology|December 6, 2015
Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 casesArne Warth, Sandrina Körner, Roland Penzel, et al.
International Journal of Oncology|December 12, 2018
Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancerRebecca Weber, Michael Meister, Thomas Muley, et al.
Histopathology|August 14, 2012
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsiesArne Warth, Thomas Muley, Esther Herpel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survivalArne Warth, Thomas Muley, Michael Meister, et al.
Cancers|April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for RedefinitionPhilip Baum, Samantha Taber, Stella Erdmann, et al.
Frontiers in Oncology|June 5, 2023
Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Frontiers in Oncology|December 9, 2022
Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
Frontiers in Oncology|February 17, 2022
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative StudyMarc A Schneider, Adriana Rozy, Sabine Wrenger, et al.
Pageof 23